用类药物合物向瘤:展示关键进展和障碍
Keykavous Parang1, Thuy Do1, Clare Dinh1
1Department of Biomedical and Pharmaceutical Sciences, Center for Targeted Drug Delivery, Chapman University School of Pharmacy, Irvine, CA, USA.
Drug design, development and therapy
|February 19, 2026
概括
类药物联合体 (PDCs) 提供有针对性的癌症治疗,增强瘤透能力. 本综述探讨了PDC设计,优势,挑战以及改善药物输送和疗效的未来方向.
科学领域:
- 瘤学和制药科学 医疗科学
- 药物输送系统 药物输送系统
- 纳米医学是一种纳米医学.
背景情况:
- 类药物合物 (PDCs) 是一种有针对性的疗法,它结合了同源和细胞毒性有效载荷.
- 由于其较小的尺寸,PDCs比抗体-药物合物 (ADC) 具有优势,可使瘤透更深,清除更快.
- 它们的模块化设计允许定制向,链接器和药物有效载荷.
研究的目的:
- 审查最近在类药物联合体 (PDC) 设计和癌症治疗中的应用方面取得的进展.
- 讨论由PDCs调解的瘤传递和细胞内药物释放的机制.
- 突出目前的挑战和PDC发展的未来方向.
主要方法:
- 关于PDC设计,机制和应用的最新进展的文献综述.
- 对关键设计元素的分析:向,链接器和有效载荷.
- 在临床前和临床环境中 PDC 的说明性示例.
主要成果:
- 与ADC相比,PDC利用类向来增强药物传递到瘤,显示出优越的组织透能力.
- 机制包括受体结合,内细胞分裂和刺激反应链接剂用于药物释放.
- 诸如ANG1005, (177Lu) -DOTATATE和LyP-1-doxorubicin结合物的例子表明了PDC的潜力.
结论:
- PDCs为向癌症治疗提供了一个有希望的平台,在稳定性,瘤异质性和制造方面面临着持续的挑战.
- 监管障碍和临床挫折,如梅尔弗鲁芬,突出需要进一步发展.
- 未来的方向包括神经神经PDCs,AI优化和纳米材料集成以提高有效性.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
31
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
31
Modified-Release Drug Delivery Systems: Site-Targeted
29
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
29
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K


